Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Completed · Phase 4

Conditions studied: Obsessive Compulsive Disorder

In brief

The purpose of this study is to assess the efficacy of Escitalopram in the treatment of obsessive compulsive disorder and to determine the optimal treatment dose.

Key facts

Study ID
NCT00116532
Run by
Massachusetts General Hospital
People needed
30
Starts
2002-10-01
Expected to finish
2007-02-01
Last updated by the study team
2007-04-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.